Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
UBS
Citi
Accenture
Cipla
Mallinckrodt
Cantor Fitzgerald
Daiichi Sankyo

Generated: October 19, 2018

DrugPatentWatch Database Preview

ESTRADIOL VALERATE Drug Profile

« Back to Dashboard

When do Estradiol Valerate patents expire, and when can generic versions of Estradiol Valerate launch?

Estradiol Valerate is a drug marketed by Fosun Pharma, Luitpold, Watson Labs, and Watson Labs Inc. and is included in five NDAs.

The generic ingredient in ESTRADIOL VALERATE is estradiol valerate. There are seventy-five drug master file entries for this compound. Two suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the estradiol valerate profile page.

Drug patent expirations by year for ESTRADIOL VALERATE
Pharmacology for ESTRADIOL VALERATE
Ingredient-typeEstradiol Congeners
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists
Synonyms for ESTRADIOL VALERATE
(17.beta.)-Estra-1,3,5(10)-triene-3,17-diol 17-valerate
(17beta)-3-hydroxyestra-1(10),2,4-trien-17-yl pentanoate
(1S,10R,11S,14S,15S)-5-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2,4,6-TRIEN-14-YL PENTANOATE
(1S,10R,11S,14S,15S)-5-HYDROXY-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5-TRIEN-14-YL PENTANOATE
(1S,11S,14S,15S,10R)-5-hydroxy-15-methyltetracyclo[8.7.0.0<2,7>.0<11,15>]hepta deca-2,4,6-trien-14-yl pentanoate
(1S,11S,14S,15S,10R)-5-hydroxy-15-methyltetracyclo[8.7.0.0<2,7>.0<11,15>]hepta deca-2(7),3,5-trien-14-yl pentanoate
(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl pentanoate
[(8R,9S,13S,14S,17S)-13-methyl-3-oxidanyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate
[(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] pentanoate
1,3,5(10)-Estratriene-3,17beta-diol 17-pentanote
124683-EP2295426A1
124683-EP2295427A1
17-BETA-ESTRADIOL 17-VALERATE
17-pentanoyl-estra-1,3,5(10)-triene-3,17beta-diol
17|A-Estradiol-17-valerate
3-Hydroxy-17beta-valeroyloxyestra-1,3,5(10)-triene
69557-95-5
907-12-0
979-32-8
979E328
A845765
AB00382980_15
AB0106305
AC1L22HN
AKOS005267158
API0002610
ARONIS24416
Atladiol
B-Estradiol 17-valerate
B1506
BB_NC-0486
BBC/580
beta-Estradiol 17-valerate
beta-Estradiol 17-valerate, 98% 1g
C12859
CAS-979-32-8
CCG-221130
CCRIS 5571
CHEBI:31561
CHEMBL1511
Climaval
component of Deluteval 2X
component of Ditate
component of Mal-O-Fem L.A
CPD000058346
CS-2904
Cyclocur
D01413
Deladiol
Deladumone (TN)
Delahormone unimatic
Delestrogen
Delestrogen 4X
Depo estro med
Depo-Estro-Med
DSSTox_CID_3004
DSSTox_GSID_23004
DSSTox_RID_76827
DTXSID8023004
Dura-estradiol
Duratrad
E0876
EBD28143
EINECS 213-559-2
Estate
Estra-1,3,5(10)-triene-3,17-diol (17-beta)-, 17-pentanoate
Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-, 17-pentanoate
Estra-1,3,5(10)-triene-3,17-diol(17beta)-, 17-pentanoate
Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 17-pentanoate
Estradiol 17-valerate
Estradiol 17?-valerate
Estradiol 17.beta.-valerate
Estradiol 17beta-valerate
Estradiol Depot
Estradiol valerate (JAN/USP/INN)
Estradiol valerate (VAN)
Estradiol valerate [USAN:INN:JAN]
Estradiol valerate [USP:INN:BAN:JAN]
Estradiol valerianate
Estradiol-17-valerate; 1,3,5(10)-Estratriene-3,17b-diol 17-pentanote
ESTRADIOL, 17-VALERATE
Estradioli valeras
Estradioli valeras [INN-Latin]
Estraval
Estraval 2X
Estraval PA
Estroval-10
Exten strone
Femogen-L.A
Femogen-L.A.
Femogex
GTPL7655
Gynogen L.A. 10
Gynogen L.A. 20
Gynogen L.A. 40
Gynogen L.A.10
Gynogen LA
Gynokadin
HMS2232L17
HMS3259C12
HY-B0672
KS-5213
LMST02010039
LP106555
LS-64737
MCULE-6732064308
Merimono
MFCD00056541
MLS000028449
MLS001146931
MolPort-002-507-065
NC00560
NCGC00094673-01
Neofollin
NSC 17590
NSC-17590
NSC17590
Nuvelle
Oestradiol valerate
Oestradiol-17b-valerate
OKG364O896
Opera_ID_444
Pelanin
Pelanin depot
pentanoate d'estra-1,3,5(10)-tri ne-3-ol-17|A-yle
pentanoic acid [(8R,9S,13S,14S,17S)-3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl] ester
Pharlon
PL000289
PL007004
Postoval
Primogyn-Depot
Primogyna
Progynon-Depot
Progynova
Q-201506
Repo-Estra
Ronfase
RSEPBGGWRJCQGY-RBRWEJTLSA-N
s3149
SBB080821
SCHEMBL40563
SMR000058346
SR-01000003061
SR-01000003061-3
ST075188
ST24046695
Tox21_111312
UNII-OKG364O896
Valerate d'estradiol
Valerate d'estradiol [INN-French]
Valerato de estradiol
Valerato de estradiol [INN-Spanish]
Valergen
ZINC3881556

US Patents and Regulatory Information for ESTRADIOL VALERATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fosun Pharma ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 040628-001 Oct 4, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 083714-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 090920-001 Jan 19, 2010 AO RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs Inc ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 083547-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fosun Pharma ESTRADIOL VALERATE estradiol valerate INJECTABLE;INJECTION 040628-002 Oct 4, 2007 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
UBS
Citi
Accenture
Cipla
Mallinckrodt
Cantor Fitzgerald
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.